CCR2 and neoplasm: Since the above experiment describes that CCR2+HSC-derived cells can differentiate into functional APCs in vitro, we sought to determine if HSC-derived cells can cross-prime adoptively transferred tumor-reactive T cells used for adoptive cellular therapy.